AZD3229 Tosylate is primarily utilized in the field of oncology research as a potent and selective inhibitor targeting specific kinase pathways involved in cancer progression. Its application is focused on preclinical studies to evaluate its efficacy in inhibiting tumor growth and metastasis, particularly in cancers driven by aberrant kinase activity. Researchers employ this compound to investigate its potential as a therapeutic agent, often using in vitro and in vivo models to assess its pharmacokinetics, pharmacodynamics, and safety profile. Additionally, it is explored for its ability to overcome resistance mechanisms in certain cancer types, making it a valuable tool in the development of next-generation targeted therapies.